Company intelligence / Profile preview

M-TAG

Sydney, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

M-TAG (Medical Technology Advisory Group) was a premier health economics and market access consultancy based in Sydney, Australia, serving the global pharmaceutical and medical device industries. Founded in 1997, the company specialized in providing strategic advice and technical services related to reimbursement, health technology assessment (HTA), and outcomes research, particularly within the Asia-Pacific region. M-TAG was widely recognized for its expertise in navigating the complex Australian Pharmaceutical Benefits Scheme (PBS) and Medical Services Advisory Committee (MSAC) processes. In 2005, the company was acquired by IMS Health (now IQVIA) to bolster its global health economics and outcomes research (HEOR) capabilities and establish a strong presence in the APAC market.

Industry: Consulting

Beyond the preview

Go deeper on M-TAG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M-TAG.

Explore the full profile